EcoDrugPlus

Mtor Associated Protein, Lst8 Homolog (S. Cerevisiae)

Ensembl ID : ENSGMOG00000005385
Gene Symbol: MLST8
3 Cross references
200 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSGMOG00000004181
Gene Symbol: NAALAD2
1 Cross references
340 Possible Orthologues:

Npc1-Like 1

Ensembl ID : ENSGMOG00000016777
Gene Symbol: NPC1L1
2 Cross references
189 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSGMOG00000035055
Gene Symbol: LOC115561798
3 Cross references
180 Possible Orthologues:

P2y Purinoceptor 2-Like

Ensembl ID : ENSGMOG00000010909
Gene Symbol: LOC115560821
2 Cross references
192 Possible Orthologues:

P2y Purinoceptor 2-Like

Ensembl ID : ENSGMOG00000032895
Gene Symbol: LOC115560619
2 Cross references
192 Possible Orthologues:

Ph_bcr_vertebrate And Rhogap_bcr Domain-Containing Protein

Ensembl ID : ENSGMOG00000002945
Gene Symbol: SI:DKEY-91M11.5
3 Cross references
196 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSGMOG00000008563
Gene Symbol: PTK6B
3 Cross references
159 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSGMOG00000004015
Gene Symbol: PIM1
2 Cross references
246 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSGMOG00000006809
Gene Symbol: PIM3
2 Cross references
172 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSGMOG00000017678
Gene Symbol: LOC115546645
2 Cross references
163 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSGMOG00000016976
Gene Symbol: RAF1A
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).